Description
Structure & Identity
SLU-PP-332 is a synthetic small-molecule compound, not a peptide, so it has no amino-acid sequence. It acts as a pan-agonist across all three estrogen-related receptors, ERRα, ERRβ, and ERRγ, which is the basis for its use as a reference compound in ERR and metabolic-signaling research. It is supplied as a lyophilized small molecule, identity and purity confirmed by HPLC and mass spectrometry on each batch.
Research Background
SLU-PP-332 research centers on ERR signaling and cellular energy metabolism.
- ERR agonist. SLU-PP-332 is a synthetic small molecule that activates the ERRα, β, and γ receptors [PMID: 37739806].
- Metabolic-signaling model. A synthetic ERR agonist has been studied in metabolic-signaling cell models [PMID: 37739806].
- Exercise-response signaling. ERR agonism and acute aerobic-exercise responses have been examined [PMID: 36988910].
- Mitochondrial function. ERR agonism has been studied for effects on mitochondrial function and biogenesis [PMID: 37717940].
- Analytical work. In-vitro metabolism and analytical characterization of SLU-PP-332 has been reported [PMID: 41588687].
These are preclinical research contexts, not approved uses, and the compound is intended for laboratory study.
Specifications
| Attribute | Value |
| Chemical name | SLU-PP-332 |
| Also Known As | pan-ERR agonist |
| Type | Synthetic small molecule (not a peptide) |
| Receptor target | ERRα / ERRβ / ERRγ |
| CAS number | 303760-60-3 |
| Molecular weight | 290.32 Da |
| Purity | ≥99% by HPLC |
| Identity | Confirmed by HPLC/MS |
| Physical form | Capsule (supplied as 100 units) |
| Quantity | 30 mg |
| Storage | -20°C, protected from light |
| Solubility | Dissolve in an appropriate research solvent |
| Classification | Research use only |
Storage & Handling
Store the product frozen at -20°C and shielded from light until use. As a small-molecule compound, it should be kept dry and sealed; let it reach room temperature before opening to limit condensation. Prepare working solutions in an appropriate solvent for your research and store them according to the compound’s stability.
Quality Assurance
SLU-PP-332 is produced to research-grade standards and verified by an independent lab before release. Identity and purity are confirmed by HPLC and mass spectrometry, with testing carried out by third-party laboratories, including Janoshik Analytical and domestic US labs. As a non-peptide small molecule, it is assessed by identity and purity testing appropriate to its chemistry rather than by peptide-specific assays. A certificate of analysis accompanies each batch.
Frequently Asked Questions
Is SLU-PP-332 a peptide?
No. SLU-PP-332 is a synthetic small molecule, an agonist of the estrogen-related receptors (ERRs). It is studied in metabolic research and supplied for research use only.
What is an “ERR agonist”?
ERRs (estrogen-related receptors) help control how cells produce and use energy. An agonist activates them, and SLU-PP-332 activates all three ERR subtypes.
What is SLU-PP-332 studied for?
Researchers have examined whether it produces ERR-mediated metabolic-signaling effects studied alongside exercise responses. That framing is a research description, not a claim about outcomes.
Is SLU-PP-332 FDA approved?
No, SLU-PP-332 is not FDA approved. It is a research-use-only compound and is not for human or veterinary use.
Does SLU-PP-332 get peptide-style testing?
No, because it is not a peptide, it is assessed by identity and purity testing suited to a small molecule, not by peptide-specific assays like amino-acid analysis.
How should SLU-PP-332 be stored?
Keep it frozen at -20°C, protected from light, and let it reach room temperature before opening.
How is SLU-PP-332 verified?
It is tested to ≥99% purity by HPLC with mass-spec identity confirmation by an independent lab, and each batch ships with a certificate of analysis.
